Status:
UNKNOWN
Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation
Lead Sponsor:
Medical University of Vienna
Conditions:
Liver Transplantation
Blood Loss
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases h...
Eligibility Criteria
Inclusion
- patients listed for OLT with positive screening for IDA
Exclusion
- Age \<18 years
- Hemochromatosis
- Iron utilization disorders
- Non-IDA
- Therapy with erythropoietin-stimulating agents or intravenous iron within 4 weeks prior to screening
- Previous allergic reactions against intravenous iron formulations
- Transfusion within 2 weeks prior to screening
- Complete portal vein thrombosis
- High-urgency OLT
- Pregnancy
- Sepsis or severe infection
- Immunosuppressive therapy
Key Trial Info
Start Date :
July 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04475887
Start Date
July 23 2020
End Date
May 31 2023
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna, Department of Surgery
Vienna, Austria, 1090